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Abstract 16 
Antifreeze proteins (AFPs) are essential components of many organisms adaptation to cold 17 
temperatures. Fish type III AFPs are divided into two groups, SP isoforms being much less 18 
active than QAE1 isoforms. Two type III AFPs from Zoarces viviparus, a QAE1 (ZvAFP13) 19 
and an SP (ZvAFP6) isoform, are here characterized and their crystal structures determined. 20 
We conclude that the higher activity of the QAE1 isoforms cannot be attributed to single 21 
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residues, but rather a combination of structural effects. Furthermore both ZvAFP6 and 22 
ZvAFP13 crystal structures have water molecules around T18 equivalent to the tetrahedral-23 
like waters previously identified in a neutron crystal structure. Interestingly, ZvAFP6 forms 24 
dimers in the crystal, with a significant dimer interface. The presence of ZvAFP6 dimers was 25 
confirmed in solution by native electrophoresis and gel filtration. To our knowledge this is 26 
the first report of dimerization of AFP type III proteins.   27 
Keywords: Antifreeze protein, Zoarces viviparus, crystal structure, dimerization, protein 28 
purification 29 
Abbreviations: TH (thermal hysteresis), Thf (hysteresis freezing point), Tm (melting point), 30 
Tf (freezing point), AFP (antifreeze protein), IBS (ice binding site) 31 
 32 
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  36 
1. Introduction 37 
Ectothermic animals that are frequently exposed to temperatures below the melting point 38 
(Tm) of their body fluids must either avoid freezing of their body fluids and survive the low 39 
temperatures or be able to tolerate ice formation in their tissues [22]. The body fluids of fish 40 
living in ice laden waters have a temperature similar to that of the surrounding water. The Tm 41 
of the body fluids is higher than that of the sea water, hence the fish are supercooled, and 42 
should in principle freeze when they ingest or touch an ice crystal [9].  43 
Antifreeze proteins (AFPs) are an essential component of the adaptations many of these 44 
animals have evolved to survive low temperatures [7,9]. AFPs inhibit the growth of ice 45 
crystals to a certain extent. The inhibition of the ice growth depresses the temperature at 46 
which already present ice crystals grow, the hysteresis freezing point (Thf), without changing 47 
the melting point (Tm) that is predicted by Raoult´s law (the colligative freezing point 48 
depression). This separation of the Thf and the Tm is termed thermal hysteresis (TH) or 49 
antifreeze activity. It is still debated how AFPs inhibit ice crystal growth; however, the 50 
general consensus is that the AFPs recognize and bind to various ice surface planes. Ice 51 
growth is restricted to the regions between the adsorbed AFPs causing an increase in local 52 
curvature which makes it less favorable for water molecules to join the ice crystal eventually 53 
leading to an arrest in its growth [24,30]. The morphology of the ice crystals usually changes 54 
to bipyramidal when fish AFPs are absorbed at the ice crystal’s surface [9].  55 
Type III AFPs have so far been found in fish belonging to the Zoarcoidei suborder (two 56 
Antarctic and five Northern hemisphere species).  Type III AFPs are divided into two groups 57 
designated SP and QAE after their ability to bind to the ion-exchange matrices SP- and QAE-58 
sepharose, respectively. The two groups share ~50% sequence identity, while within groups 59 
the sequence identity is ~90% for the SP group and ~75% for the QAE group. An alignment 60 
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of representative type III AFP sequences is shown in Figure 1. Several reports have shown 61 
that the QAE isoforms are more active in terms of TH compared to SPs, which are inactive in 62 
this respect. A QAE subgroup (QAE2) is also impaired in terms of antifreeze activity.  63 
However, SPs, as QAEs, induce the characteristic bipyramidal ice crystal morphology [2,6]. 64 
The role of the SPs is still unknown, but in vitro the QAE1s and SPs from Zoarces elongatus 65 
have been shown to co-operate and thereby increase the TH activity to the levels of TH found 66 
in vivo [21]. 67 
The AFPs investigated in this study originate from Zoarces viviparus caught in Roskilde 68 
fjord. Previous studies have shown by sequence analysis that the AFPs from Z. viviparus 69 
belong to type III [1,27]. NMR studies of one of them, ZvAFP13, have shown secondary 70 
structure elements similar to other type III AFPs [1].  71 
Here we report the expression, purification and X-ray crystal structures for two type III AFPs 72 
from Z. viviparus, ZvAFP13 representing the QAE1 and ZvAFP6 representing the SP 73 
isoform classes, respectively.  74 
  75 
2. Materials and methods 76 
Unless otherwise stated, general laboratory chemicals were from Sigma-Aldrich, vectors and 77 
strains from Novagen, and enzymes for molecular biology from Fermentas. 78 
Genes, cloning and expression: cDNA had been reverse transcribed from mRNA encoding 79 
for ZvAFP6 and ZvAFP13 that was isolated from Z. viviparus, ligated into pGEM-T Easy 80 
vector (Promega) and transformed into JM109 Escherichia coli cells (Promega). JM109 E. 81 
coli cells (Promega) with pGEM-T Easy vector (Promega) carrying the genes encoding for 82 
ZvAFP6 (KC622345) and ZvAFP13 (ABN42205) were amplified from the vector by PCR. 83 
The mature genes were ligated with T4 DNA ligase into the pET-26b vector after digestion 84 
with NdeI and XhoI. After transformation into the E. coli BL21 (DE3), cells were grown at 85 
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28°C in LB medium supplemented with 50 µg/ml Kanamycin until cell growth reached 86 
OD600 0.7-0.8. To induce expression, 0.5 mM isopropyl thio-β-d-galactoside was added to the 87 
LB medium, and the cultures were grown at 28°C for further 16-18 hours. The cells were 88 
then pelleted (5000g for 20 min at 4°C), resuspendend in 1/10 volume of 50 mM sodium 89 
acetate at pH 8 and lysed by sonication. 90 
Purification: the pH of the supernatant obtained after sonication was adjusted to 4 using 99% 91 
acetic acid in order to precipitate most of the non AFPs. The samples were centrifuged 92 
(12000g for 20 min at 4°C) and the supernatant applied to a 5 ml HiTrap SP HP cation-93 
exchange column (GE Healthcare) at a flow rate of 0.5 ml/min with a linear NaCl gradient 94 
(0–1 M) in 50 mM NaOAc buffer pH 4. The peak fractions were checked for TH and 95 
bipyrimidal ice crystal formation. The fractions containing the AFP were pooled and stored at 96 
-20°C. The purity was checked on 15% SDS/PAGE gels. The pooled fractions were 97 
concentrated using Amicon Ultra 15 centrifugal filter devices with a molecular cut off at 3 98 
kDa (Millipore). The concentration of the protein samples was measured by the BCA Protein 99 
Assay Kit (Thermo Fischer Scientific). 100 
Activity: TH was determined as described in Nishimiya et al. [21] and Ramløv [23] using a 101 
Nanoliter Osmometer (Otago Osmometers). A cooling rate of 1°C pr. min was used and an 102 
annealing time of 1 minute. The ice crystals were as small as possible while still being visible 103 
under the microscope.   104 
Native MW estimation: Gel filtration was carried out at 4°C in a 50 mM NaOAc buffer at pH 105 
4.0 containing 0.3 M NaCl using a Superdex 75 column (10/300 GL) and the following 106 
proteins as MW standards: aldolase (158 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 107 
kDa) and ribonuclease A (13.7 kDa). Detection of ZvAFP6 was carried out at A214 due to the 108 
low abundance of aromatics. 109 
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For native PAGE 12% gels were used. The gels were run at RT at 150 V for 1.5 h (XCell 110 
SureLock© Mini-Cell system; Invitrogen) in 30 mM MES, 30mM histidine, pH 6.1 and with 111 
reversed cathode and anode. Ribonuclease A was used as standard.  112 
Crystallization: Initial screenings were setup at RT with an Oryx 8 crystallization robot 113 
(Douglas Instruments) in MRC 2 sitting drop plates (Douglas Instruments). Initial conditions 114 
were optimized in hanging drops in 24 well VDX plates (Hampton Research) with a drop 115 
volume of 4 µl and a reservoir volume of 1 ml. ZvAFP13 crystals grew in 2.5 M (NH4)2SO4, 116 
0.1 M citric acid, pH 4.5 with a protein stock concentration of 2mg/ml. ZvAFP6 crystals 117 
grew in similar conditions; however, the pH of the citric acid was 4.0 and the protein 118 
concentration was 10 mg/ml. 119 
Data collection and processing: A ZvAFP13 and a ZvAFP6 crystal were flash frozen in 120 
liquid nitrogen and X-ray data were collected at beamline 911-2 at Maxlab, Lund, Sweden at 121 
100 K with a maximum resolution of 1.45 Å for ZvAFP13 and 1.2 Å for ZvAFP6. Data were 122 
processed using XDS [15]. For ZvAFP13 the space group was determined to be P212121 with 123 
1 molecule in the asymmetric unit. For ZvAFP6 the space group was determined to be C2221 124 
with 2 molecules in the asymmetric unit. Data collection statistics are shown in Table 1. 125 
Structure determination and refinement: the structures of ZvAFP6 and ZvAFP13 were 126 
determined by the molecular replacement method with PDB ID 1OPS and 4MSI respectively 127 
as search models using Molrep [28]. Cycles of refinement using Refmac5 [20] were 128 
alternated with cycles of manual model building in Coot [8]. In the last rounds of refinements 129 
the structures were refined anisotropically. The final structures were evaluated with several 130 
validation tools including Molprobity [3]. Refinement statistics are in Table 1.  131 
 132 
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Bioinformatics: For the sequence analysis the type III AFPs sequences deposited at the 133 
National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine 134 
(http://www.ncbi.nlm.nih.gov/genbank/) were retrieved and aligned using the program 135 
MAFFT [16]. The alignments were visualized using BOXSHADE 136 
(http://www.ch.embnet.org/software/BOX_form.html). Pymol was used to visualize 3D-137 
structures (Schrödinger), while the PISA server was used to analyze the interfaces [18]. 138 
3. Results 139 
Purification: The main purification step in the final procedure was a pH precipitation. The 140 
ion-exchange step originally carried out after the pH precipitation actually decreases the 141 
purity of ZvAFP13 with respect to higher MW contaminants; therefore this step was later 142 
omitted. Furthermore, difficulties were encountered in concentrating the fractions from the 143 
ion-exchange step, while the protein could be brought without difficulty to the concentrations 144 
necessary for crystallization by concentrating the supernatant from the pH precipitation step. 145 
Activity: Both isoforms induced the previously observed bipyramidal ice crystal morphology. 146 
The QAE1 isoform ZvAFP13 had a TH of 0.38±0.03ºC at a concentration of 1 mg/ml and of 147 
0.96±0.01ºC at a concentration of 5 mg/ml. This activity is comparable or higher than the 148 
activity reported for other QAE1 isoforms produced recombinantly, as for example in [21] or 149 
purified from fish [29]. The SP isoform ZvAFP6 was completely inactive on its own up to a 150 
concentration of 10 mg/ml. However, added to ZvAFP13 with both proteins at a 151 
concentration of 1 mg/ml nearly doubled the activity (0.75±0.02ºC).  152 
Crystal structures: Well diffracting crystals were obtained for both ZvAFP6 and ZvAFP13. 153 
ZvAFP13 crystallizes isomorphously to many other reported type III AFPs [5,13,17], while 154 
ZvAFP6 crystallizes, as the first reported type III AFP, in the space group C2221 with two 155 
molecules in the asymmetric unit forming a dimer in the crystal (see Discussion).  156 
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The crystal structure of ZvAFP13 was determined to a 1.45Å resolution. The Cα rmsd with 157 
the MR model (PDB ID 4MSI) was 0.384 Å over 52 residues aligned. The structure of the SP 158 
isoform, ZvAFP6, was determined to 1.2 Å resolution, representing the first high resolution 159 
structure of a SP isoform. The Cα rmsd with the MR model (PDB ID 1OPS) was 0.295  Å for 160 
the A chain of ZvAFP6 and 0.268 Å for the B chain, after omitting the two last C-terminal 161 
residues of the A chain which are clearly in a different conformation and are not modeled in 162 
the B chain. The fold of ZvAFP13 and ZvAFP6 (Figure 2a) is very similar to all other type 163 
III AFPs and comprises a compact, globular, single domain.  164 
Overall the electron density is well defined for both proteins, except for the termini. In 165 
ZvAFP13, the first three N-terminal residues (M0, N1 and Q2) and the last C-terminal 166 
residue modeled (P65) have poor electron density. Alternate conformations are noted in 167 
Table 1. All other side chains had excellent electron density showing a single conformation. 168 
In ZvAFP6 the N-terminal M could not be modeled, either due to disorder or protease activity 169 
found in E. coli [19]. Disorder was also observed at the C-terminus, where P65 and Y63 are 170 
the last modeled residues for chains A and B respectively, with poor density for the two last 171 
residues modeled. In chain B only the side chain density is less defined for the stretch K25-172 
S30.  E36 (both chains) and M56A show poor side chain density. Alternate conformations are 173 
given in Table 1. P29 is a cis-proline in both structures. Additional refinement and 174 
geometrical quality information are in Table 1. Final R-factors/R-frees were 13.4%/17.6% for 175 
ZvAFP13 and 17.9%/19.5% for ZvAFP6 respectively after anisotropic refinement.  176 
The rmsd for Cα atoms between ZvAFP6 (chain A) and ZvAFP13 was 0.63 Å. Between the 177 
A and B chain of ZvAFP6 it was 0.49 Å for all atoms and 0.20 for Cα atoms only. 178 
Native oligomeric state of ZvAFP6: in order to see if the dimeric state of ZvAFP6 in the 179 
crystals is also present in solution, gel filtration was carried out. Comparison with standards 180 
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shows a MW of around 11 kDa most consistent with a dimer for the most prominent peak 181 
(Figure 3A). Native PAGE cannot be run under standard conditions for ZvAFP6 because of 182 
its high pI, however by reversing the current it can be electrophoresed at pH 6.1. ZvAFP6 183 
runs close to a ribonuclease A standard, which has approximately the same pI (9.5 vs 9.3 as 184 
calculated for ZvAFP6) and double the MW (13.7 kDa) of a ZvAFP6 monomer (Figure 3B). 185 
Similar experiments carried out for ZvAFP13 were not conclusive and the MW in solution 186 
could not be clearly established.    187 
4. Discussion 188 
Expression and purification: A modification of the protocol by Nishimiya et al. [21] for 189 
expression of soluble type III AFPs in E. coli was followed for the Z. viviparus AFPs. Since 190 
type III AFPs are still active at low pH [4], the pH of the lysate could be  lowered to pH 4, 191 
where most E. coli proteins precipitated, and an almost pure AFP preparation was obtained, 192 
which was suitable for structural studies without further purification.  193 
Activity: Nishimiya et al. [21] previously showed that SP and QAE1 type III AFPs from Z. 194 
elongatus act in a cooperative manner. Z. viviparus produces both QAE1s and SPs AFPs, and 195 
when combined they also act in a cooperative manner. 196 
Structural determinants for QAEs and SPs differences in activities: The hydration layer of 197 
type III AFPs has been subject of many investigations [14,25,26] since the original studies 198 
showing that at the ice binding site (IBS) of HPLC12 from M. americanus the water structure 199 
is ice-like [12,31]. Howard et al. [14] found a cluster of four water molecules, one with 200 
weaker density that was close to a tetrahedral geometry in the vicinity of T18, which was 201 
used to build a model for the ice face. Equivalents of these waters could be identified in both 202 
ZvAFP13 and  ZvAFP6, though they are not present in the previously published SP structure 203 
 10 
 
(PDB ID 1OPS) [32], so no obvious difference can be seen in the water structure organization 204 
near the IBS for QAE1 and SP variants according to the structures presented here.   205 
The involvement of residues Q9, L10, I13, N14, T15, A16, T18, L19, V20, M21, V41 and 206 
Q44 at the IBS has been verified by mutational analysis of the QAE1 isoform HPLC12 from 207 
M. americanus [2,6,13]. Most of these residues are very well conserved in both QAE and SP 208 
proteins, with some variation at Q9 (V in QAE2), I13 (sometimes M in SPs), L19 (V in 209 
QAE2s and mostly P in SPs), V20 (G in QAE2s and mostly A in SPs), M21 (one exception), 210 
V41 (sometimes an I in QAEs). Recently an inactive QAE2 protein (nfeAFP11) was 211 
conferred active similar to an active QAE1 variant through triple or quadruple mutations 212 
(V9Q/V19L/G20V and V9Q/V19L/G20V/I41V), underlying the importance of these residues 213 
[10]. 214 
The most consistent differences between QAE1s and SPs are L19, which in SPs is mostly P, 215 
and V20, which in SPs is mostly an A.  These two residues were shown to be important for 216 
the differences between QAE1 and SP in an investigation by Granham et al. [11] who 217 
produced the P19L/A20V variant of a SP isoform (nfeAFP6) from Z. elongatus improving its 218 
ability to slow down the ice crystal growth 30-fold, however without conferring the ability to 219 
arrest ice growth completely. Clearly these residues, while important, do not present the full 220 
story, as for example the QAE1 isoform AB1 from Austrolycicthys brachycephalus is active 221 
(1.27 °C at 2.9mM) and contains P19/A20 [4] like the SP isoforms generally do.  Another 222 
QAE1, AM1 from Anarhichas minor, has P19/I20 at this position. P19/A20 is also not fully 223 
conserved in SPs: the Uniprot sequence associated with PDB 1OPS has P19/V20, HPLC1 224 
from M. americanus has P19/V20, nfeAFP1, 3 and 4 have L19/A20. All QAE2s have 225 
V19/G20. 226 
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We note that the nature of the residue at position 37 (I in most QAEs and M in many SPs) is 227 
correlated with position 19.  AB1, the fully active QAE1 protein mentioned above, which 228 
unusually has a P at position 19 also has a M at position 37. Am1 that contains P19 has I37 229 
though, but the activity of Am1 is unknown. As exemplified by the superposition of the 230 
ZvAFP13 and ZvAFP6 structures (Figure 2D), L19 and I37 are within contact distance (3.8 Å 231 
from L CD2 to I CG2) and it maybe that I at this position is necessary to stabilize the V 232 
position. Furthermore if residue 37 were a M it could be expected to destabilize V19, as it 233 
would result in contacts as short as 2.5 Å, if it were in the same position as in the ZvAFP6 234 
structure. Thus it could be that an I at position 37 is necessary to fully reap the benefits of L 235 
at position 19.  236 
K61 is also a residue that has been discussed in the literature. Mutation of K61 to I affects ice 237 
growth inhibition activity and the residue is thought to position N14 correctly, while R47 and 238 
D58 form a salt bridge stabilizing the loop on which K61 resides [13]. Since SP isoforms 239 
usually lack R47 and/or D58 these residues could play a role in the difference from QAEs as 240 
suggested in [11]. However we observe that in both molecules of ZvAFP6 and in PDB ID 241 
1OPS, K61 and N14 are positioned as in ZvAFP13 and other QAEs even though the SPs lack 242 
the salt bridge forming residues. 243 
Dimerization of ZvAFP6: The most interesting feature in the ZvAFP6 structure is that the 244 
protein forms non-covalent dimers in the crystal as detected by analysis with the PISA server 245 
[18]. The interface in the dimers covers an area of approximately 500 Å2 solvent accessible 246 
surface per monomer (compared to about 3500 Å2 of total accessible surface for each 247 
monomer). The dimer is formed by protein molecules related crystallographically by a two 248 
fold axis. The observation of dimers formed by two separate polypeptide chains is to our 249 
knowledge unprecedented for type III AFPs, and according to the PISA server prediction the 250 
interaction observed in the crystal is strong enough to be of biological relevance in solution. 251 
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Gel filtration and native PAGE analysis further supported the formation of dimers in solution 252 
for ZvAFP6. Since these techniques are affected by the molecular shape, the shape of the 253 
ZvAFP6 dimer observed in the crystal was compared to the crystal structure of bovine 254 
ribonuclease A (PDB code 5RSA). Both molecules had slightly elongated shapes. 255 
Ribonuclease A has dimensions of about 38 Å in the longest dimension and 20-25 Å in the 256 
shortest dimensions (excluding a small 2 residues N-terminal protrusion). The dimer of 257 
ZvAFP6 formed in the crystal has also a longer dimension of about 38-39 Å and shorter 258 
dimensions around 23-25 Å. Thus it seems reasonable to assume that the results of gel 259 
filtration and the native PAGE are reliable.  260 
It is interesting to note that ZvAFP13 is crystallized under similar high sulphate conditions, 261 
but does not show dimerization in the crystals; unfortunately, determination of the MW in 262 
solution was not conclusive. Two of the residues discussed up to now and which tend to be 263 
different in SPs and QAEs, P19 and M37, are very important in dimerization (Figure 2C). 264 
F34, fully conserved among the SPs and not found in any of the QAEs, seems also to be 265 
essential in forming the interface (Figure 2C).  266 
In the only other available SP crystal structure (PDB ID 1OPS), dimers are not formed. This 267 
is hard to rationalize in terms of the few residues that are different between ZvAFP6 and 268 
1OPS at the interface, but may be due to differences in the crystallization conditions for 269 
1OPS, perhaps destabilizing dimerization.  270 
Dimers as observed in the ZvAFP6 crystals could affect ice binding (either favourably or 271 
unfavourably), since when the IBS in one of the monomers is bound, the N- and C-terminal 272 
tail of the other monomer in the dimer as well as loop 26-35 would protrude towards the ice 273 
face. While the biological relevance of dimerization is at this moment in time highly 274 
speculative, the demonstration of dimers both in the crystal and in solution for the SP type 275 
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ZvAFP6 opens a new dimension for research in the structure-function relationships of AFP 276 
type III.   277 
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7. Figures and tables 364 
Table1: Data collection and refinement statistics. 365 
Figure 1: Sequence alignment of type III antifreeze proteins mentioned in the discussion. 366 
Asterisks  indicate ice binding residues, residues with grey background are the mutations that 367 
are mentioned in text, and residues with black background are the ones that are important in 368 
dimerization of ZvAFP6.  369 
Figure 2a-d: A) Superimposition of ZvAFP6 (orange), ZvAFP13 (green), RD1 from 370 
Lycodichthys dearborni (pink) (PDB ID: 1UCS), HPLC12 from Zoarces americanus 371 
(yellow) (PDB ID: 4MSI), and HPLC3 from Zoarces americanus (blue) (PDB ID: 1OPS). B) 372 
superimposition of presumed ice binding residues of ZvAFP6 (orange) and ZvAFP13 (green). 373 
C) The interface between ZvAFP chain a (orange) and chain b (purple). F34 and M37 are 374 
presented as sticks and the ice binding site residues are presented as spheres, with carbon 375 
atoms colored as the rest of the monomer, sulfur in yellow, oxygen in red and nitrogen in 376 
blue.   D) Overlay of residues 19 and 37 from ZvAFP6 (orange) and ZvAFP13 (green). 377 
Figure 3: Native oligomeric state of ZvAFP6 in solution. A) Gel filtration trace, with 378 
Ribonuclease A in black (13.7 KDa) and ZvAFP6 in grey. The major peak corresponds to a 379 
size of circa 11 kDa Inset: SDS-PAGE of loaded ZvAFP6 sample (S) and selected fractions 380 
(F1-F3, 1 mL fractions between 12-15 mL elution volume). M are the MW markers (97 to 14 381 
kDa) ) B: Native PAGE of ZvAFP6 and Ribonuclease A. 382 
Table1: Data collection and refinement statistics. 
Protein ZvAFP13  ZvAFP6  
PDB code 4UR4 4UR6 
Space group  P212121  C2221  
Unit cell dimensions (a, b, c 
in Å) 
32.26; 39.69; 44.22  75.57; 108.17; 38.25 
Resolution  1.45-29.54 (1.45-1.49)  1.20-30.0 (1.20-1.23)  
Completeness (%)  98.0  (92.5)  98.5 (94.9)  
Redundancy  4.4 (3.4)  6.2 (5.0) 
Rrim (%) 4.0 (31.1) 3.1 (42.7) 
No. of reflections  45146 (2448)  300182 (17280)  
No. of unique reflection  10321 (715)  48601 (3431) 
I/σI  24.2 (4.7)  25.2 (5.2) 
Rwork  0.134  0.179  
Rfree  0.176  0.195  
Rmsd bonds (Å) 0.015 0.018 
Rmsd angles (º) 1.864 1.819 
Modelled solvent and other 
components 
90 water molecules 205 water molecules 
2 sulphate ions 
Residues in alternate 
conformation 
Q2, Q9, L10, E25, T28, M30, 
P38, L40, S42, M43, L55 and 
Y63 
L10(A), I13(B), S30(A/B), 
M37(A/B), Q39(A), 
L55(A/B), D58(A). 
Ramachandran plot   
(Molprobity) 
Residues in favored regions 
(%)  
98.4  100.0  
Residues in  allowed regions 
(%)  
100.0  100.0 
Outliers None None 
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